New study tests safer, faster fertility option for PCOS patients

NCT ID NCT07171970

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two fertility treatments for women with polycystic ovary syndrome (PCOS): a simpler in vitro maturation (IVM) method with fresh embryo transfer versus standard in vitro fertilization (IVF) with frozen embryo transfer. The goal is to see which approach leads to more live births while reducing risks like ovarian hyperstimulation syndrome. About 600 women will take part, and the results could help doctors choose the best, safest option for PCOS patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
estradiol valerate, progesterone, dydrogesterone, follicle-stimulating hormone (FSH)
What this could lead to
If successful, this could offer women with PCOS a simpler, safer fertility treatment that avoids the risk of ovarian hyperstimulation syndrome and reduces time to pregnancy.
What could go wrong
This is a single-center trial, and results may not apply to all clinics. The IVM approach may have lower success rates than IVF, and fresh transfer could increase cycle cancellation risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRESH EMBRYO TRANSFER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IVFMD - My Duc Hospital

    RECRUITING

    Ho Chi Minh City, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.